{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T19:52:03Z","timestamp":1649015523532},"reference-count":28,"publisher":"Impact Journals, LLC","issue":"49","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,10,17]]},"DOI":"10.18632\/oncotarget.20696","type":"journal-article","created":{"date-parts":[[2017,9,7]],"date-time":"2017-09-07T21:28:45Z","timestamp":1504819725000},"page":"85868-85882","source":"Crossref","is-referenced-by-count":1,"title":["ELAS1 induces apoptotic death in adenocarcinoma DU145 and squamous-cell carcinoma SAS cancer cells, but not in normal KD cells"],"prefix":"10.18632","volume":"8","author":[{"given":"Toshihiro","family":"Uchihashi","sequence":"first","affiliation":[{"name":"First Department of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Osaka University, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Ota","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Yabuno","sequence":"additional","affiliation":[{"name":"First Department of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Osaka University, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouichi","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohshiro","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Naito","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikihiko","family":"Kogo","sequence":"additional","affiliation":[{"name":"First Department of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Osaka University, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norikazu","family":"Yabuta","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nojima","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,8,24]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1158\/0008-5472","article-title":"Impact of Pattern Recognition Receptors on the Prognosis of Breast Cancer Patients Undergoing Adjuvant Chemotherapy","volume":"76","author":"Kroemer","year":"2016","journal-title":"Cancer Res"},{"key":"2","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nrm831","article-title":"Cellular roles of DNA topoisomerases: a molecular perspective","volume":"3","author":"Wang","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3","doi-asserted-by":"publisher","first-page":"6106","DOI":"10.1093\/nar\/gku284","article-title":"A fine-scale dissection of the DNA double-strand break repair machinery and its implications for breast cancer therapy","volume":"42","author":"Khanna","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fonc.2016.00163","article-title":"Novel Biological Approaches for Testing the Contributions of Single DSBs and DSB Clusters to the Biological Effects of High LET Radiation","volume":"6","author":"Iliakis","year":"2016","journal-title":"Front Oncol"},{"key":"5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bbcan.2012.09.002","article-title":"Topoisomerase degradation, DSB repair, p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitors","volume":"1835","author":"Kaina","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0167-4781(98)00129-8","article-title":"Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme","volume":"1400","author":"Strumberg","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"7","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2165\/00003495-200262140-00004","article-title":"Camptothecins: a review of their chemotherapeutic potential","volume":"62","author":"Swaan","year":"2002","journal-title":"Drugs"},{"key":"8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/bmc.1345","article-title":"Irinotecan and its active metabolite, SN-38: review of bioanalytical methods and recent update from clinical pharmacology perspectives","volume":"24","author":"Srinivas","year":"2010","journal-title":"Biomed Chromatogr"},{"key":"9","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.1038\/onc.2015.47","article-title":"ELAS1-mediated inhibition of the cyclin G1-B\u2019\u03b3 interaction promotes cancer cell apoptosis via stabilization and activation of p53","volume":"34","author":"Nojima","year":"2015","journal-title":"Oncogene"},{"key":"10","doi-asserted-by":"publisher","first-page":"604","DOI":"10.4161\/cc.11.3.19114","article-title":"Cyclin G-associated kinase regulates protein phosphatase 2A by phosphorylation of its B\u2019\u03b3 subunit","volume":"11","author":"Nojima","year":"2012","journal-title":"Cell Cycle"},{"key":"11","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.molcel.2009.02.015","article-title":"From promiscuity to precision: protein phosphatases get a makeover","volume":"33","author":"Shenolikar","year":"2009","journal-title":"Mol Cell"},{"key":"12","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.4161\/cc.24878","article-title":"Recruitment of cyclin G2 to promyelocytic leukemia nuclear bodies promotes dephosphorylation of \u03b3H2AX following treatment with ionizing radiation","volume":"12","author":"Nojima","year":"2013","journal-title":"Cell Cycle"},{"key":"13","doi-asserted-by":"crossref","first-page":"39091","DOI":"10.1038\/srep39091","article-title":"Comprehensive phenotypic analysis of knockout mice deficient in cyclin G1 and cyclin G2","volume":"6","author":"Uchihashi","year":"2016","journal-title":"Sci Rep"},{"key":"14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1097-2765(02)00504-X","article-title":"Cyclin G recruits PP2A to dephosphorylate Mdm2","volume":"9","author":"Prives","year":"2002","journal-title":"Mol Cell"},{"key":"15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1158\/1535-7163.MCT-08-0457","article-title":"PP2A regulates ionizing radiation-induced apoptosis through Ser46 phosphorylation of p53","volume":"8","author":"Larner","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"16","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1101\/gad.190678.112","article-title":"Mutant p53: one name, many proteins","volume":"26","author":"Prives","year":"2012","journal-title":"Genes Dev"},{"key":"17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","article-title":"Mutant p53 in cancer: new functions and therapeutic opportunities","volume":"25","author":"Vousden","year":"2014","journal-title":"Cancer Cell"},{"key":"18","doi-asserted-by":"publisher","first-page":"a026179","DOI":"10.1101\/cshperspect.a026179","article-title":"Somatic TP53 Mutations in the Era of Genome Sequencing","author":"Pfeifer","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"19","doi-asserted-by":"crossref","first-page":"E1874","DOI":"10.3390\/ijms17111874","article-title":"p53 Proteoforms and Intrinsic Disorder: An Illustration of the Protein Structure-Function Continuum Concept","volume":"17","author":"Uversky","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"20","first-page":"S381","article-title":"RNA interference targeting mutant p53 inhibits growth and induces apoptosis in DU145 human prostate cancer cells","volume":"28","author":"Xie","year":"2011","journal-title":"Med Oncol"},{"key":"21","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/pros.22583","article-title":"Functional p53 determines docetaxel sensitivity in prostate cancer cells","volume":"73","author":"Gao","year":"2013","journal-title":"Prostate"},{"key":"22","doi-asserted-by":"publisher","first-page":"9551","DOI":"10.1073\/pnas.1200019109","article-title":"Data-driven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors","volume":"109","author":"Soussi","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"23","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1101\/gad.1381906","article-title":"Requirement of clathrin heavy chain for p53-mediated transcription","volume":"20","author":"Taya","year":"2006","journal-title":"Genes Dev"},{"key":"24","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.2147\/OTT.S63049","article-title":"Oncolytic viruses as immunotherapy: progress and remaining challenges","volume":"9","author":"Aurelian","year":"2016","journal-title":"Onco Targets Ther"},{"key":"25","doi-asserted-by":"publisher","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-10-2333","article-title":"Telomerase-dependent oncolytic adenovirus sensitizes human cancer cells to ionizing radiation via inhibition of DNA repair machinery","volume":"70","author":"Fujiwara","year":"2010","journal-title":"Cancer Res"},{"key":"26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1158\/1535-7163","article-title":"Dual programmed cell death pathways induced by p53 transactivation overcome resistance to oncolytic adenovirus in human osteosarcoma cells","volume":"12","author":"Fujiwara","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"27","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/cas.13027","article-title":"Oncolytic virus therapy: A new era of cancer treatment at dawn","volume":"107","author":"Todo","year":"2016","journal-title":"Cancer Sci"},{"key":"28","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/cbdd.12055","article-title":"The future of peptide-based drugs","volume":"81","author":"Price","year":"2013","journal-title":"Chem Biol Drug Des"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T17:19:26Z","timestamp":1596734366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,24]]},"references-count":28,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2017,10,17]]}},"alternative-id":["20696","29156763"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.20696","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,24]]}}}